Symbol="GERN"
AssetType="Common Stock"
Name="Geron Corporation"
Description="Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California."
CIK="886744"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="149 COMMONWEALTH DRIVE, SUITE 2070, MENLO PARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1327882000"
EBITDA="-173563008"
PERatio="None"
PEGRatio="-2.38"
BookValue="0.572"
DividendPerShare="0"
DividendYield="0"
EPS="-0.36"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-386.54"
ReturnOnAssetsTTM="-0.333"
ReturnOnEquityTTM="-0.777"
RevenueTTM="450000"
GrossProfitTTM="-93668000"
DilutedEPSTTM="-0.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.603"
AnalystTargetPrice="4.83"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="571.98"
PriceToBookRatio="8.28"
EVToRevenue="493.55"
EVToEBITDA="-6.08"
Beta="0.859"
num_52WeekHigh="3.84"
num_52WeekLow="1.95"
num_50DayMovingAverage="3.109"
num_200DayMovingAverage="2.749"
SharesOutstanding="508767000"
DividendDate="None"
ExDividendDate="None"
symbol="GERN"
open="2.68"
high="2.70"
low="2.38"
price="2.63"
volume="9912188.00"
latest_trading_day="2023-08-21"
previous_close="2.61"
change="0.02"
change_percent="0.7663%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="38"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="5614715"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="99"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_negative_thumbnail_id_2="122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0054.jpeg"
image_neutral_thumbnail_id_1="567"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_neutral_thumbnail_id_2="551"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_positive_thumbnail_id_1="655"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0053.jpeg"
image_positive_thumbnail_id_2="606"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
